Skip to content

Evaluation of Educational Tools for Pregnant Women

Evaluation of Educational Tools Concerning Hypertension in Ambulatory Pregnant Women, Compared With Usual Antenatal Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01858324
Enrollment
247
Registered
2013-05-21
Start date
2014-03-31
Completion date
2014-09-30
Last updated
2014-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Keywords

Preeclampsia, Hypertensive disorders of pregnancy, Patient education, Educationnal tools, Pamphlet, Video, Knowledge, Anxiety, Satisfaction

Brief summary

Hypertensive disorders of pregnancy happen in 5% of pregnancies. Being aware of symptoms and complications may help women to present early and preserve their own and their baby's health. The proposed research aims to evaluate the impact of educational tools in pregnant women from an ambulatory population. These tools include a detailed pamphlet (including a graphic-based summary), a magnet summarizing symptoms and appropriate action, and a video. Level of knowledge will be evaluated after one month with a validated questionnaire. We will also evaluate if getting more information about preeclampsia increases patient anxiety as well as satisfaction about the tools.

Detailed description

Background: Preeclampsia is a leading cause of maternal/fetal morbidity/mortality. Pregnant women are often poorly informed on preeclampsia and seeking care too late results in maternal/fetal complications. Many healthcare providers believe that delivering information for low-risk women only make them more anxious. Preliminary data: We published that an information pamphlet on preeclampsia increases knowledge, without increasing anxiety, and generates high satisfaction in women hospitalized for preeclampsia. Objectives: Demonstrate that (1) ambulatory low-risk pregnant women will benefit from the pamphlet/video with improved knowledge; (2) without any increase in anxiety, and with great satisfaction. Design: Prospective randomized controlled pilot study. Inclusion criteria: consecutive pregnant women aged ≥18 y.o. between 200-326 weeks presenting at the clinic and who read/write French or English. Exclusion criteria: Anticipated delivery or termination within one month. Intervention: pamphlet, magnet and video. Control: no educational tool. At baseline, women in both groups will answer questionnaire #1 on demographics; one month later: self-administered questionnaire #2 on knowledge, anxiety, satisfaction. Sample size: N=178 will provide 80% power to find a significant improvement of at least 20% in knowledge score and 96% power to find a difference of at least 1 on scale for anxiety (alpha of 5%). Assuming a drop-out rate of 10%, missing answers \<20%, and rate of answered questionnaire #2 of 50%, 400 subjects will be recruited. Anticipated results: The tools will improve knowledge by about 20% in intervention group compared to control group. They will not increase anxiety over one point and will be highly appreciated by women.

Interventions

OTHEREducational tools

Subjects will receive the educational tools. They will then receive one month after a questionnaire about knowledge, anxiety and satisfaction.

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women between 20+0 to 32+6 weeks pregnant * Aged 18 years old or more * Who present at the Blood Sampling in Pregnancy clinic * With an adequate understanding of written and spoken French or English in order to read the pamphlet and fill out the self-administered questionnaire

Exclusion criteria

* Consideration of an interruption of pregnancy for maternal or fetal reasons * Anticipated delivery within the next month.

Design outcomes

Primary

MeasureTime frameDescription
Knowledge about preeclampsia1 monthThrough a questionnaire (7 questions, 35 statements, one global score)

Secondary

MeasureTime frameDescription
Anxiety1 monthQuestion 1: 8 statements (Likert's scale 1 to 6) Question 2 more general
Satisfaction1 month3 questions

Other

MeasureTime frameDescription
Sub-group analysis: category of health care provider1 monthDifferences between control and intervention group according to category of healthcare provider
Sub-group analysis: preeclampsia risk factors1 monthDifferences between control and intervention group according to preeclampsia risk factors (pre-pregnancy diseases or a history of preeclampsia
Sub-group analysis: tobacco use1 monthDifferences between control and intervention group according to tobacco use
Sub-group analysis:1 monthDifferences between control and intervention group according to employment type
Sub-group analysis: ethnicity1 monthDifferences between control and intervention group according to ethnicity
Sub-group analysis: age1 monthDiferences in outcomes between control and intervention groups according to group age
Sub-group analysis: educational level1 monthDifferences between control and intervention group according to educational level
Sub-group analysis: marital status1 monthDifferences between control and intervention group according to marital status
Sub-group analysis:video viewed on site vs. at home1 monthDifferences between control and intervention group according to video viewed on-site vs. at home
Sub-group analysis:delay since last consultation of the tools1 monthDifferences between control and intervention group according to delay since last consultation of the tools.
Sub-group analysis: socio-economic level1 monthDifferences between control and intervention group according to socio-economic level
Sub-group analysis: parity1 monthDifferences between control and intervention group according to parity.
Sub-group analysis: pre-pregnancy BMI1 monthDifferences between control and intervention group according to pre-pregnancy BMI

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026